- Home
- AQST vs GAU Comparison
AQST vs GAU Comparison
Compare AQST & GAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AQST | GAU |
|---|---|---|
| Founded | 2004 | 1999 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 809.3M | 731.5M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | AQST | GAU |
|---|---|---|
| Price | $5.88 | $2.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $8.83 | $3.00 |
| AVG Volume (30 Days) | 2.3M | ★ 2.5M |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $43,397,000.00 | ★ $352,642,000.00 |
| Revenue This Year | N/A | $82.50 |
| Revenue Next Year | $52.69 | $57.71 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 111.43 |
| 52 Week Low | $2.12 | $1.00 |
| 52 Week High | $7.55 | $3.12 |
Technical Indicators
Market Signals| Indicator | AQST | GAU |
|---|---|---|
| Relative Strength Index (RSI) | 44.66 | 58.95 |
| Support Level | $5.61 | $2.41 |
| Resistance Level | $6.44 | $2.64 |
| Average True Range (ATR) | 0.31 | 0.13 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 16.00 | 80.00 |
Price Performance
Historical ComparisonAbout AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About GAU Galiano Gold Inc.
Galiano Gold Inc is focused on building a sustainable business capable of long term value creation for its stakeholders through a combination of exploration, accretive acquisitions, and disciplined deployment of its financial resources. The company currently operates and manages: Nkran, Esaase, Abore and Miradani North, multiple satellite deposits and exploration projects located on the Asankrangwa Gold Belt in the Amansie West District of the Republic of Ghana (Ghana), West Africa.